Pictet Asset Management Holding SA Has $517.97 Million Stock Holdings in Xylem Inc. $XYL

Pictet Asset Management Holding SA trimmed its holdings in Xylem Inc. (NYSE:XYL) by 11.3% during the first quarter, Holdings Channel reports. The institutional investor owned 4,334,794 shares of the industrial products company’s stock after selling 551,458 shares during the quarter. Pictet Asset Management Holding SA’s holdings in Xylem were worth $517,965,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Knuff & Co LLC bought a new position in Xylem in the 3rd quarter valued at about $27,000. Board of the Pension Protection Fund acquired a new position in Xylem during the 4th quarter valued at about $27,000. Commonwealth Retirement Investments LLC bought a new stake in Xylem during the 4th quarter worth approximately $27,000. Wexford Capital LP purchased a new stake in shares of Xylem in the third quarter worth approximately $27,000. Finally, Ramirez Asset Management Inc. lifted its holdings in shares of Xylem by 100.0% in the third quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company’s stock valued at $30,000 after purchasing an additional 100 shares in the last quarter. 87.96% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, Director Jerome A. Peribere purchased 1,210 shares of the stock in a transaction that occurred on Monday, May 4th. The shares were bought at an average price of $116.61 per share, with a total value of $141,098.10. Following the acquisition, the director owned 27,209 shares of the company’s stock, valued at $3,172,841.49. This trade represents a 4.65% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the transaction, the chief accounting officer owned 3,605 shares in the company, valued at approximately $423,443.30. The trade was a 54.22% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.32% of the stock is owned by corporate insiders.

Xylem Stock Down 0.3%

Shares of NYSE:XYL opened at $116.60 on Friday. Xylem Inc. has a 1 year low of $105.29 and a 1 year high of $154.27. The company has a market capitalization of $27.71 billion, a PE ratio of 29.00, a price-to-earnings-growth ratio of 1.66 and a beta of 1.04. The business has a fifty day moving average price of $113.05 and a two-hundred day moving average price of $125.38. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.46 and a quick ratio of 1.10.

Xylem (NYSE:XYL) last released its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. The company had revenue of $2.12 billion for the quarter, compared to analysts’ expectations of $2.11 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The business’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the previous year, the business posted $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Analysts forecast that Xylem Inc. will post 5.51 earnings per share for the current year.

Xylem Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th were paid a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date was Thursday, May 28th. Xylem’s payout ratio is presently 42.79%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on XYL shares. Barclays decreased their price target on Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a report on Wednesday, April 29th. Citigroup lowered their target price on shares of Xylem from $174.00 to $168.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. Weiss Ratings lowered shares of Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Stifel Nicolaus reduced their price objective on shares of Xylem from $163.00 to $159.00 and set a “buy” rating for the company in a research report on Wednesday, April 29th. Finally, Oppenheimer decreased their price objective on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a research note on Wednesday, April 29th. Eight equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $153.54.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.